Elastic liposomes for topical and transdermal drug delivery
- PMID: 20072873
- DOI: 10.1007/978-1-60327-360-2_4
Elastic liposomes for topical and transdermal drug delivery
Abstract
Elastic liposomes have been developed and evaluated as novel topical and transdermal delivery systems. They are similar to conventional liposomes but with the incorporation of an edge activator in the lipid bilayer structure to provide elasticity. Elastic liposomes are applied non-occluded to the skin and have been shown to permeate through the stratum corneum lipid lamellar regions as a result of the hydration or osmotic force in the skin. They have been investigated as drug carriers for a range of small molecules, peptides, proteins and vaccines, both in vitro and in vivo. Following topical application, structural changes in the stratum corneum have been identified and intact elastic liposomes visualised within the stratum corneum lipid lamellar regions, but no intact liposomes have been identified in the deeper viable tissues. The method by which they transport their drug payload into and through the skin has been investigated but remains an area of contention. This chapter provides an overview of the development, characterisation and evaluation of elastic liposomes for delivery into and via the skin.
Similar articles
-
Elastic liposomes for topical and transdermal drug delivery.Curr Drug Deliv. 2009 Jul;6(3):217-26. doi: 10.2174/156720109788680813. Curr Drug Deliv. 2009. PMID: 19604135 Review.
-
Elastic Liposomes for Topical and Transdermal Drug Delivery.Methods Mol Biol. 2017;1522:107-117. doi: 10.1007/978-1-4939-6591-5_9. Methods Mol Biol. 2017. PMID: 27837534
-
Transfersomes for transdermal drug delivery.Expert Opin Drug Deliv. 2006 Nov;3(6):727-37. doi: 10.1517/17425247.3.6.727. Expert Opin Drug Deliv. 2006. PMID: 17076595 Review.
-
Application of liposomes as potential cutaneous drug delivery systems. In vitro and in vivo investigation with radioactively labelled vesicles.J Drug Target. 1996;4(2):95-101. doi: 10.3109/10611869609046267. J Drug Target. 1996. PMID: 8894969
-
Delivery of hydrocortisone from liposomal suspensions to the hairless mouse skin following topical application under non-occlusive and occlusive conditions.J Microencapsul. 1998 Jan-Feb;15(1):21-9. doi: 10.3109/02652049809006832. J Microencapsul. 1998. PMID: 9463804
Cited by
-
An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis.Sci Rep. 2024 May 23;14(1):11792. doi: 10.1038/s41598-024-62428-x. Sci Rep. 2024. PMID: 38783008 Free PMC article. Clinical Trial.
-
Preparation of redispersible liposomal dry powder using an ultrasonic spray freeze-drying technique for transdermal delivery of human epithelial growth factor.Int J Nanomedicine. 2014 Mar 31;9:1665-76. doi: 10.2147/IJN.S59463. eCollection 2014. Int J Nanomedicine. 2014. PMID: 24729702 Free PMC article.
-
Tocopheryl phosphate mixture (TPM) as a novel lipid-based transdermal drug delivery carrier: formulation and evaluation.Drug Deliv Transl Res. 2017 Feb;7(1):53-65. doi: 10.1007/s13346-016-0331-x. Drug Deliv Transl Res. 2017. PMID: 27672079
-
Luteolin-Loaded Elastic Liposomes for Transdermal Delivery to Control Breast Cancer: In Vitro and Ex Vivo Evaluations.Pharmaceuticals (Basel). 2021 Nov 11;14(11):1143. doi: 10.3390/ph14111143. Pharmaceuticals (Basel). 2021. PMID: 34832925 Free PMC article.
-
Optimizing and Evaluating the Transdermal Permeation of Hydrocortisone Transfersomes Formulation Based on Digital Analysis of the In Vitro Drug Release and Ex Vivo Studies.Recent Adv Drug Deliv Formul. 2022;16(2):122-144. doi: 10.2174/2667387816666220608115605. Recent Adv Drug Deliv Formul. 2022. PMID: 35676851 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical